Global Nasal Flu Vaccine Market Growth 2022-2028
- LP 4805638
- 70 Pages
- January 2022
- Pharmaceuticals
The United States Nasal Flu Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nasal Flu Vaccine market, reaching US$ million by the year 2028. As for the Europe Nasal Flu Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nasal Flu Vaccine players cover AstraZeneca, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Flu Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Child
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nasal Flu Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nasal Flu Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nasal Flu Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Nasal Flu Vaccine Segment by Type
2.2.1 Trivalent Flu Vaccine
2.2.2 Quadrivalent Flu Vaccine
2.3 Nasal Flu Vaccine Sales by Type
2.3.1 Global Nasal Flu Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Nasal Flu Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nasal Flu Vaccine Sale Price by Type (2017-2022)
2.4 Nasal Flu Vaccine Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Nasal Flu Vaccine Sales by Application
2.5.1 Global Nasal Flu Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Nasal Flu Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nasal Flu Vaccine Sale Price by Application (2017-2022)
3 Global Nasal Flu Vaccine by Company
3.1 Global Nasal Flu Vaccine Breakdown Data by Company
3.1.1 Global Nasal Flu Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Nasal Flu Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Nasal Flu Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Nasal Flu Vaccine Revenue by Company (2020-2022)
3.2.2 Global Nasal Flu Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Nasal Flu Vaccine Sale Price by Company
3.4 Key Manufacturers Nasal Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nasal Flu Vaccine Product Location Distribution
3.4.2 Players Nasal Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nasal Flu Vaccine by Geographic Region
4.1 World Historic Nasal Flu Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Nasal Flu Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nasal Flu Vaccine Annual Revenue by Geographic Region
4.2 World Historic Nasal Flu Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Nasal Flu Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nasal Flu Vaccine Annual Revenue by Country/Region
4.3 Americas Nasal Flu Vaccine Sales Growth
4.4 APAC Nasal Flu Vaccine Sales Growth
4.5 Europe Nasal Flu Vaccine Sales Growth
4.6 Middle East & Africa Nasal Flu Vaccine Sales Growth
5 Americas
5.1 Americas Nasal Flu Vaccine Sales by Country
5.1.1 Americas Nasal Flu Vaccine Sales by Country (2017-2022)
5.1.2 Americas Nasal Flu Vaccine Revenue by Country (2017-2022)
5.2 Americas Nasal Flu Vaccine Sales by Type
5.3 Americas Nasal Flu Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Flu Vaccine Sales by Region
6.1.1 APAC Nasal Flu Vaccine Sales by Region (2017-2022)
6.1.2 APAC Nasal Flu Vaccine Revenue by Region (2017-2022)
6.2 APAC Nasal Flu Vaccine Sales by Type
6.3 APAC Nasal Flu Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nasal Flu Vaccine by Country
7.1.1 Europe Nasal Flu Vaccine Sales by Country (2017-2022)
7.1.2 Europe Nasal Flu Vaccine Revenue by Country (2017-2022)
7.2 Europe Nasal Flu Vaccine Sales by Type
7.3 Europe Nasal Flu Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nasal Flu Vaccine by Country
8.1.1 Middle East & Africa Nasal Flu Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nasal Flu Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Nasal Flu Vaccine Sales by Type
8.3 Middle East & Africa Nasal Flu Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Flu Vaccine
10.3 Manufacturing Process Analysis of Nasal Flu Vaccine
10.4 Industry Chain Structure of Nasal Flu Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nasal Flu Vaccine Distributors
11.3 Nasal Flu Vaccine Customer
12 World Forecast Review for Nasal Flu Vaccine by Geographic Region
12.1 Global Nasal Flu Vaccine Market Size Forecast by Region
12.1.1 Global Nasal Flu Vaccine Forecast by Region (2023-2028)
12.1.2 Global Nasal Flu Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nasal Flu Vaccine Forecast by Type
12.7 Global Nasal Flu Vaccine Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Nasal Flu Vaccine Product Offered
13.1.3 AstraZeneca Nasal Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
14 Research Findings and Conclusion
Table 1. Nasal Flu Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nasal Flu Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Trivalent Flu Vaccine
Table 4. Major Players of Quadrivalent Flu Vaccine
Table 5. Global Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Nasal Flu Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Nasal Flu Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Nasal Flu Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Nasal Flu Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Nasal Flu Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Nasal Flu Vaccine Revenue by Application (2017-2022)
Table 13. Global Nasal Flu Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Nasal Flu Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Nasal Flu Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Nasal Flu Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Nasal Flu Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Nasal Flu Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Nasal Flu Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Nasal Flu Vaccine Producing Area Distribution and Sales Area
Table 21. Players Nasal Flu Vaccine Products Offered
Table 22. Nasal Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nasal Flu Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Nasal Flu Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Nasal Flu Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Nasal Flu Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Nasal Flu Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Nasal Flu Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Nasal Flu Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Nasal Flu Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Nasal Flu Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Nasal Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Nasal Flu Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Nasal Flu Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Nasal Flu Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Nasal Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Nasal Flu Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Nasal Flu Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Nasal Flu Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Nasal Flu Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Nasal Flu Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Nasal Flu Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Nasal Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Nasal Flu Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Nasal Flu Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Nasal Flu Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Nasal Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Nasal Flu Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Nasal Flu Vaccine
Table 66. Key Market Challenges & Risks of Nasal Flu Vaccine
Table 67. Key Industry Trends of Nasal Flu Vaccine
Table 68. Nasal Flu Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Nasal Flu Vaccine Distributors List
Table 71. Nasal Flu Vaccine Customer List
Table 72. Global Nasal Flu Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Nasal Flu Vaccine Sales Market Forecast by Region
Table 74. Global Nasal Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Nasal Flu Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Nasal Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Nasal Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Nasal Flu Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Nasal Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Nasal Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Nasal Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Nasal Flu Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Nasal Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Nasal Flu Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Nasal Flu Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Nasal Flu Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Nasal Flu Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Nasal Flu Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Nasal Flu Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Nasal Flu Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Nasal Flu Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. AstraZeneca Basic Information, Nasal Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Nasal Flu Vaccine Product Offered
Table 94. AstraZeneca Nasal Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
List of Figures
Figure 1. Picture of Nasal Flu Vaccine
Figure 2. Nasal Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Flu Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nasal Flu Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nasal Flu Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Trivalent Flu Vaccine
Figure 10. Product Picture of Quadrivalent Flu Vaccine
Figure 11. Global Nasal Flu Vaccine Sales Market Share by Type in 2021
Figure 12. Global Nasal Flu Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Nasal Flu Vaccine Consumed in Child
Figure 14. Global Nasal Flu Vaccine Market: Child (2017-2022) & (K Units)
Figure 15. Nasal Flu Vaccine Consumed in Adult
Figure 16. Global Nasal Flu Vaccine Market: Adult (2017-2022) & (K Units)
Figure 17. Global Nasal Flu Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Nasal Flu Vaccine Revenue Market Share by Application in 2021
Figure 19. Nasal Flu Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Nasal Flu Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Nasal Flu Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Nasal Flu Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Nasal Flu Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Nasal Flu Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Nasal Flu Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Nasal Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Nasal Flu Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Nasal Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Nasal Flu Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Nasal Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Nasal Flu Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Nasal Flu Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Nasal Flu Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Nasal Flu Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Nasal Flu Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Nasal Flu Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Nasal Flu Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Nasal Flu Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Nasal Flu Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Nasal Flu Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Nasal Flu Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Nasal Flu Vaccine
Figure 63. Industry Chain Structure of Nasal Flu Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
